Crossject Asset Resilience Ratio

Latest as of June 2022: 1.31%

Crossject asset resilience ratio. Crossject (ALCJ) has an Asset Resilience Ratio of 1.31% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Crossject defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€362.00K

≈ $423.22K USD Cash + Short-term Investments

Total Assets

€27.66 Million

≈ $32.33 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Crossject (2014–2021)

Asset resilience ratio of Crossject from 2014 to 2021. This chart shows how Crossject's Asset Resilience Ratio has changed over time. Read ALCJ current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Crossject's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Crossject asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€181.00K	0.65%
Short-term Investments	€181.00K	0.65%
Total Liquid Assets	€362.00K	1.31%

Asset Resilience Insights

Limited Liquidity: Crossject maintains only 1.31% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Crossject Industry Peers by Asset Resilience Ratio

Compare Crossject's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Gan & Lee Pharmaceuticals Co Ltd SHG:603087	Medical Instruments & Supplies	7.81%
Andon Health Co Ltd SHE:002432	Medical Instruments & Supplies	18.11%
Caina Technology Co. Ltd. SHE:301122	Medical Instruments & Supplies	19.55%
QITIAN Technology Group Co Ltd SHE:300061	Medical Instruments & Supplies	0.00%
Visco Vision Inc. TW:6782	Medical Instruments & Supplies	0.98%
Mark Dynamics Indonesia Tbk PT JK:MARK	Medical Instruments & Supplies	6.64%
Medeon Biodesign TWO:6499	Medical Instruments & Supplies	32.68%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%

Crossject Asset Resilience Ratio by Year (2014–2021)

Crossject asset resilience ratio by year from 2014 to 2021. The table below shows the annual Asset Resilience Ratio data for Crossject.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	0.98%	€308.00K ≈ $360.08K	€31.52 Million ≈ $36.86 Million	+0.12pp
2020-12-31	0.86%	€288.42K ≈ $337.19K	€33.59 Million ≈ $39.27 Million	+0.02pp
2019-12-31	0.84%	€205.98K ≈ $240.81K	€24.49 Million ≈ $28.64 Million	+0.25pp
2018-12-31	0.59%	€118.30K ≈ $138.31K	€20.16 Million ≈ $23.57 Million	-1.27pp
2017-12-31	1.86%	€329.16K ≈ $384.82K	€17.72 Million ≈ $20.71 Million	+1.26pp
2016-12-31	0.60%	€85.68K ≈ $100.17K	€14.25 Million ≈ $16.66 Million	-3.48pp
2015-12-31	4.08%	€566.17K ≈ $661.91K	€13.88 Million ≈ $16.23 Million	+3.56pp
2014-12-31	0.52%	€95.68K ≈ $111.86K	€18.37 Million ≈ $21.48 Million	--

pp = percentage points

About Crossject

PA:ALCJ France Medical Instruments & Supplies

Market Cap

$77.81 Million

€66.56 Million EUR

Market Cap Rank

#20013 Global

#308 in France

Share Price

€1.25

Change (1 day)

-1.11%

52-Week Range

€1.25 - €2.69

All Time High

€10.40